Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

NCT01488552 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: nab-paclitaxel
DRUG: FOLFIRINOX
GENETIC: Immunohistochemistry (IHC) Analysis
DRUG: Metformin
DRUG: mFOLFIRI

Sponsor

Pancreatic Cancer Research Team